Page 4 - Syndesi Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Syndesi therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Syndesi Therapeutics Today - Breaking & Trending Today

AbbVie buys neuroscience startup for $1 billion | Crain's Chicago Business

The Lake Bluff biotech giant buys Syndesi Therapeutics, a developer of treatments for symptoms common with diseases like Alzheimer’s. ....

North Chicago , Syndesi Therapeutics , Botox Therapeutic ,

AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio

AbbVie (NYSE: ABBV) today announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's neuroscience portfolio. This acquisition gives AbbVie access to Syndesi's portfolio of novel modulators of the synaptic vesicle protein 2A (SV2A), including its lead molecule SDI-118 . ....

Walloon Region , Waals Gewest , Cleary Gottlieb Steen , Tom Hudson , Jonathan Savidge , Jjdc Inc , Vives Fund , Goodwin Procter , Novo Holdings , Syndesi Therapeutics , Gottlieb Steen , Deloitte Legal , Allergan Aesthetics , Fountain Healthcare Partners , Johnson Innovation , Investissement De Wallonie , V Bio Ventures ,